AUTHOR=Guan Lulu , Yang Yalan , Lu Yao , Chen Yu , Luo Xi , Xin Dao , Meng Xiangrui , Shan Zhengzheng , Jiang Guozhong , Wang Feng TITLE=Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth JOURNAL=Frontiers in Pharmacology VOLUME=14 YEAR=2023 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1141420 DOI=10.3389/fphar.2023.1141420 ISSN=1663-9812 ABSTRACT=
p53 mutations are prevalent in human cancers; approximately half of patients with esophageal cancer present these mutations. Mutant p53 (mutp53) exerts oncogenic functions that promote malignant tumor progression, invasion, metastasis, and drug resistance, resulting in poor prognosis. Some small molecules have been shown to mitigate the oncogenic function of mutp53 by restoring its wild-type activity. Although these molecules have been evaluated in clinical trials, none have been successfully used in the clinic. Here, we investigated the antitumor effects of phenethyl isothiocyanate (PEITC) in p53-mutant esophageal squamous cell carcinoma (ESCC) and elucidated its mechanism to identify new therapeutic strategies. We observed that p53R248Q is a DNA contact mutation and a structural mutation and that PEITC can restore the activity of p53R248Q